Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2025 08:30 ET | Source: Fifty 1 Labs, Inc.

Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence

VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), announces the publication of a landmark technical primer on...
June 03, 2025 08:00 ET | Source: American Oncology Network

American Oncology Network Announces Research Studies Presented at ASCO 2025 Annual Meeting

American Oncology Network Announces Research Studies Presented at ASCO 2025 Annual Meeting
March 28, 2024 08:00 ET | Source: Larkspur Biosciences, Inc.

Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024

Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024
January 23, 2024 09:00 ET | Source: Unnatural Products

Unnatural Products, Inc. Enters Research Collaboration with Merck

Santa Cruz, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech company pairing AI with chemistry to enable the next generation of molecularly targeted therapeutics,...
June 21, 2023 08:30 ET | Source: Veru Inc.

Veru Inc.’s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grants

Research grants from U.S. Department of Defense (DoD) and National Cancer Institute’s Research Project Grant (NCI R01) awarded to UTHSC to study new types of targeting agents for multiple cancer...
May 03, 2023 10:00 ET | Source: NuProbe USA Inc

NuProbe BDA Technology Enables Highly Sensitive Detection of Low-Level Variants for Oncology Research

Houston, May 03, 2023 (GLOBE NEWSWIRE) -- NuProbe, a genomics company developing ultrasensitive research assays for detecting and monitoring low-frequency mutations, gene fusions, and copy number...
February 22, 2023 16:30 ET | Source: Zai Lab Limited

Zai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress

SHANGHAI, China and CAMBRIDGE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) will present two oral presentations highlighting the ad hoc interim overall...
November 07, 2022 14:32 ET | Source: NuProbe USA Inc

Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications

Hercules, Calif. and Houston, Texas, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and...
November 01, 2021 08:45 ET | Source: MPN Research Foundation

3-Year Global MPN Interferon Initiative Report Released by MPN Research Foundation

Chicago, IL, Nov. 01, 2021 (GLOBE NEWSWIRE) -- In real-world usage and in clinical trials, interferon (IFN) in a variety of forms has shown high rates of hematologic and molecular responses in many...
September 22, 2021 08:00 ET | Source: American Oncology Network

American Oncology Network & Sarah Cannon Research Institute Expand Cancer Research Collaboration with Addition of Genesis Cancer and Blood Institute

Fort Myers, Fla. & Nashville, Tenn., Sept. 22, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner...